Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Experimental & Molecular Medicine ; : 269-275, 2001.
Article in English | WPRIM | ID: wpr-144634

ABSTRACT

Adipocyte differentiation is a very complex process in which whole-cell changes are accompanied. Among them, type I procollagen gene has been shown to specifically decrease during adipocyte differentiation; however, little is known about the molecular mechanism. To examine how type I procollagen gene expression is regulated at the level of transcription during adipocyte differentiation, 3T3-L1 preadipocyte cell line was used as an in vitro model. Northern blot analysis demonstrated that mRNA expression of type I procollagen gene was dramatically reduced during adipocyte differentiation. Time-course analysis indicated that decrease in mRNA expression occurred at early stage of differentiation. Studies on several stable cell lines showed that transcriptional activities of both alpha1 and alpha2 promoters decreased significantly during adipocyte differentiation. Despite extensive deletion-promoter analyses, however, we could not identify the cis-element responsible for the switch-off of type I procollagen gene during adipocyte differentiation, suggesting that the transcriptional repression of this gene occur through general transcription machinery rather than a specific cis-element. In conclusion, down-regulation of type I procollagen mRNA expression during adipocyte differentiation is due to repression of its promoter activity through general transcription machinery.


Subject(s)
Mice , 3T3 Cells , Adipocytes/cytology , Animals , Cell Differentiation/genetics , Cell Line , Collagen Type I/genetics , Down-Regulation/genetics , Gene Expression Regulation , Genes, Reporter , Kinetics , Mutation , Procollagen/genetics , Promoter Regions, Genetic , RNA, Messenger/metabolism , Repressor Proteins/genetics , Transcription, Genetic
2.
Experimental & Molecular Medicine ; : 269-275, 2001.
Article in English | WPRIM | ID: wpr-144622

ABSTRACT

Adipocyte differentiation is a very complex process in which whole-cell changes are accompanied. Among them, type I procollagen gene has been shown to specifically decrease during adipocyte differentiation; however, little is known about the molecular mechanism. To examine how type I procollagen gene expression is regulated at the level of transcription during adipocyte differentiation, 3T3-L1 preadipocyte cell line was used as an in vitro model. Northern blot analysis demonstrated that mRNA expression of type I procollagen gene was dramatically reduced during adipocyte differentiation. Time-course analysis indicated that decrease in mRNA expression occurred at early stage of differentiation. Studies on several stable cell lines showed that transcriptional activities of both alpha1 and alpha2 promoters decreased significantly during adipocyte differentiation. Despite extensive deletion-promoter analyses, however, we could not identify the cis-element responsible for the switch-off of type I procollagen gene during adipocyte differentiation, suggesting that the transcriptional repression of this gene occur through general transcription machinery rather than a specific cis-element. In conclusion, down-regulation of type I procollagen mRNA expression during adipocyte differentiation is due to repression of its promoter activity through general transcription machinery.


Subject(s)
Mice , 3T3 Cells , Adipocytes/cytology , Animals , Cell Differentiation/genetics , Cell Line , Collagen Type I/genetics , Down-Regulation/genetics , Gene Expression Regulation , Genes, Reporter , Kinetics , Mutation , Procollagen/genetics , Promoter Regions, Genetic , RNA, Messenger/metabolism , Repressor Proteins/genetics , Transcription, Genetic
3.
Journal of Korean Medical Science ; : 653-658, 1999.
Article in English | WPRIM | ID: wpr-83042

ABSTRACT

Previous studies have demonstrated that enalapril and verapamil seem to attenuate the cyclosporine nephrotoxicity. However, the mechanisms have not been completely understood, especially on molecular events. The aim of this study was to examine the effect of individual or combined treatment on osteopontin, TGF-beta, endothelin-1 and procollagen alpha 1(I) mRNA expressions. Enalapril (50 mg/L in drinking water) and verapamil (0.5 mg/kg/day, subcutaneously), alone or in combination, were administered to rats with chronic cyclosporine nephrotoxicity (cyclosporine, 25 mg/kg/day, subcutaneously) (n = 5 each). Five rats treated with olive oil vehicle were used as control. After 4 weeks, biochemical parameters were measured, and renal cortical mRNA levels were evaluated by Northern blot analysis. Cyclosporine reduced renal creatinine clearance significantly and induced renal cortical osteopontin, TGF-beta, endothelin-1 and procollagen alpha 1(I) gene expressions around 13.5 +/- 1.3, 2.4 +/- 0.2, 1.5 +/- 0.1, 1.9 +/- 0.1 folds, respectively. Individual treatment with enalapril or verapamil significantly suppressed the osteopontin and TGF-beta mRNA expression, but not endothelin-1 and procollagen alpha 1(I). Combined treatment also inhibited the osteopontin and TGF-beta mRNA expression but there was no difference between combined and individual treatment. In conclusion, enalapril or verapamil significantly blunted the cyclosporine-induced osteopontin and TGF-beta gene expressions. However, combined treatment did not show any additive effect.


Subject(s)
Male , Rats , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Animals , Calcium Channel Blockers/therapeutic use , Cyclosporine/adverse effects , Drug Therapy, Combination , Enalapril/therapeutic use , Enalapril/administration & dosage , Endothelin-1/metabolism , Endothelin-1/genetics , Gene Expression Regulation/drug effects , Immunosuppressive Agents/adverse effects , Kidney Cortex/metabolism , Nephritis/drug therapy , Nephritis/chemically induced , Procollagen/metabolism , Procollagen/genetics , RNA, Messenger/analysis , Rats, Wistar , Sialoglycoproteins/metabolism , Sialoglycoproteins/genetics , Transforming Growth Factor beta/metabolism , Transforming Growth Factor beta/genetics , Verapamil/therapeutic use , Verapamil/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL